Abstract
Aim: Sensorineural hearing loss is correlated to massive neurological or psychiatric disease.
Materials: T1-weighted volumetric images were acquired from fourteen subjects with right-sided hearing loss (RHL), fifteen subjects with left-sided hearing loss (LHL), and twenty healthy controls (HC). Method: We treated a three-class classification problem: HC, LHL, and RHL. Stationary wavelet entropy was employed to extract global features from magnetic resonance images of each subject. Those stationary wavelet entropy features were used as input to a single-hidden layer feedforward neuralnetwork classifier. Results: The 10 repetition results of 10-fold cross validation show that the accuracies of HC, LHL, and RHL are 96.94%, 97.14%, and 97.35%, respectively. Conclusion: Our developed system is promising and effective in detecting hearing loss.Keywords: Computer-aided diagnosis, sensorineural hearing loss, single-hidden layer feed forward neural-network, stationary wavelet entropy, unilateral hearing loss.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Detection of Unilateral Hearing Loss by Stationary Wavelet Entropy
Volume: 16 Issue: 2
Author(s): Yudong Zhang, Deepak Ranjan Nayak, Ming Yang, Ti-Fei Yuan, Bin Liu, Huimin Lu and Shuihua Wang
Affiliation:
Keywords: Computer-aided diagnosis, sensorineural hearing loss, single-hidden layer feed forward neural-network, stationary wavelet entropy, unilateral hearing loss.
Abstract: Aim: Sensorineural hearing loss is correlated to massive neurological or psychiatric disease.
Materials: T1-weighted volumetric images were acquired from fourteen subjects with right-sided hearing loss (RHL), fifteen subjects with left-sided hearing loss (LHL), and twenty healthy controls (HC). Method: We treated a three-class classification problem: HC, LHL, and RHL. Stationary wavelet entropy was employed to extract global features from magnetic resonance images of each subject. Those stationary wavelet entropy features were used as input to a single-hidden layer feedforward neuralnetwork classifier. Results: The 10 repetition results of 10-fold cross validation show that the accuracies of HC, LHL, and RHL are 96.94%, 97.14%, and 97.35%, respectively. Conclusion: Our developed system is promising and effective in detecting hearing loss.Export Options
About this article
Cite this article as:
Zhang Yudong, Nayak Ranjan Deepak, Yang Ming, Yuan Ti-Fei, Liu Bin, Lu Huimin and Wang Shuihua, Detection of Unilateral Hearing Loss by Stationary Wavelet Entropy, CNS & Neurological Disorders - Drug Targets 2017; 16 (2) . https://dx.doi.org/10.2174/1871527315666161026115046
DOI https://dx.doi.org/10.2174/1871527315666161026115046 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biocompatible Targeting Hydrogels for Breast Cancer Treatment
Mini-Reviews in Medicinal Chemistry Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products
Mini-Reviews in Medicinal Chemistry Nanomedicinal Approach of Getting Across the Brood-Brain Barrier with Nanomedicinal Nanoparticles
Current Medicinal Chemistry Regulatory T Cells: Major Players in the Tumor Microenvironment
Current Pharmaceutical Design Glucose Oncometabolism of Esophageal Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Systems and Network Biology in Pharmaceutical Drug Discovery)
Current Pharmaceutical Design Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery Involvement of Targeting and Scaffolding Proteins in the Regulation of the EGFR/Ras/MAPK Pathway in Oncogenesis
Current Signal Transduction Therapy A Discussion Regarding the Application of the Hertz Contact Theory on Biological Samples in AFM Nanoindentation Experiments
Micro and Nanosystems The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Current Signal Transduction Therapy Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review
Current Cancer Drug Targets Trichostatin A - like Hydroxamate Histone Deacetylase Inhibitors as Therapeutic Agents: Toxicological Point of View
Current Medicinal Chemistry Imaging Methods in Gene Therapy of Cancer
Current Gene Therapy mTOR Inhibition and the Tumor Vasculature
Current Angiogenesis (Discontinued) Aptamers: Potential Applications to Pancreatic Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Gene Therapy: Optimising DNA Delivery to the Nucleus
Current Drug Targets Brain Targeting of siRNA via Intranasal Pathway
Current Pharmaceutical Design Emerging Roles of microRNAs in Neural Stem Cells
Current Stem Cell Research & Therapy